Response to: Correspondence on 'Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients' by Liu.

MLA

Fritzler, Marvin J., and Uriel Trahtemberg. “Response to: Correspondence on ‘Anticardiolipin and Other Antiphospholipid Antibodies in Critically Ill COVID-19 Positive and Negative Patients’ by Liu.” Annals of the Rheumatic Diseases, vol. 82, no. 8, Aug. 2023, p. e180. EBSCOhost, https://doi.org/10.1136/annrheumdis-2021-221780.

APA

Fritzler, M. J., & Trahtemberg, U. (2023). Response to: Correspondence on “Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients” by Liu. Annals of the Rheumatic Diseases, 82(8), e180. https://doi.org/10.1136/annrheumdis-2021-221780

Chicago

Fritzler, Marvin J, and Uriel Trahtemberg. 2023. “Response to: Correspondence on ‘Anticardiolipin and Other Antiphospholipid Antibodies in Critically Ill COVID-19 Positive and Negative Patients’ by Liu.” Annals of the Rheumatic Diseases 82 (8): e180. doi:10.1136/annrheumdis-2021-221780.